Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Burden of glomerular diseases in Australia: a data linkage study

    Kidney Diseases Date published:

  • Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

    American Journal of Nephrology Date published:

  • SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2

    Journal of Cardiac Failure Date published:

  • A Phase 1B Trial of Cannabidiol for Symptom Management in Kidney Failure

    Kidney International Reports Date published:

  • UTILIZING RISK PREDICTION MODELS FOR OLDER PATIENTS WITH CHRONIC KIDNEY DISEASE

    Kidney International Date published:

  • Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria

    JAMA Date published:

  • SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria

    JAMA Date published:

  • Inhaled Ciclesonide for Community-Based COVID -19: A Placebo-Controlled Randomised Trial

    Respirology Date published:

  • Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

    BMJ Open Date published:

  • Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results

    Journal of the American Society of Nephrology Date published:

  • Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study

    Journal of the American Society of Nephrology Date published:

  • Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice

    Journal of the American Society of Nephrology Date published:

  • Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset

    Journal of the American Society of Nephrology Date published:

  • Changing paradigms of studies in kidney diseases

    Kidney International Date published:

  • Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy

    Kidney International Reports Date published:

  • Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

    The Lancet Date published: